In the 90s, Sun Pharmaceuticals was a rising star. Other pharmaceutical majors Ranbaxy and Dr Reddy's looked at its growth with interest. Three decades later Dilip Shanghvi bought over Ranbaxy from Japan’s Daiichi...
Sun Pharma strikes distribution alliance with Mitsubishi Tanabe in Japan
MUMBAI: Sun PharmaBSE 0.24 % has announced a distribution alliance in Japan with Mitsubishi Tanabe for a phased transfer of manufacturing and marketing rights of 14 products that it acquired fromNovartisBSE 0.49 %...
DIVIDEND V/s BUYBACK: A Win-Win for Company and Shareholders
Sun Pharmaceuticals Industries Limited (Sun Pharma) announced that the Board of Directors of the Company at its meeting held on June 23, 2016 approved the buyback of its fully paid-up equity shares. The buyback is being...
Taro acquisition may cost Sun Pharma Rs 1,000 crore
Indian drug firm Sun Pharma may have to shell out up to Rs 1,000 crore this fiscal for acquiring Israel-based Taro Pharmaceuticals. "If we are able to get all the shares of Taro Pharmaceuticals, including promoters...